Expanded low allele frequency RAS and BRAF V600E testing in metastatic colorectal cancer as predictive biomarkers for cetuximab in the randomized CO.17 trial
| Image |  |
|---|---|
| Description | scientific article published on 21 October 2020 |
| Author/s |
author: John Zalcberg Jonathan M Loree |
| Publication date | October 21, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |